Search results for "Trichomoniasis."
showing 3 items of 3 documents
Oral trichomonosis: Description and severity of lesions in birds in Spain.
2020
Este artículo se encuentra disponible en la página web de la revista en la siguiente URL: https://www.sciencedirect.com/science/article/abs/pii/S1383576920301264 This is the pre-peer reviewed version of the following article: Martínez-Herrero, M.C., Sansano-Maestre, J., Ortega, J., González, F., López-Márquez, I., Gómez-Muñoz, M.T. et al. (2020). Oral trichomonosis: description and severity of lesions in birds in Spain. Veterinary Parasitology, vol. 283, art. 109196, which has been published in final form at https://doi.org/10.1016/j.vetpar.2020.109196. Este es el pre-print del siguiente artículo: Martínez-Herrero, M.C., Sansano-Maestre, J., Ortega, J., González, F., López-Márquez, I., Góme…
Treatment of Vaginal Trichomoniasis with a Single Dose of Tinidazole
1974
SummaryTwenty-two patients with proven vaginal trichomoniasis were treated with a single dose of 2 g. tinidazole. Twenty-one patients were cured, at both the early and the late follow-up visits. No side-effects were noted and no abnormalities of the clinical laboratory parameters were found in the trial. A historical comparison with published works was carried out and the results compared favourably with those found in the literature for tinidazole as well as for other agents used in a similar fashion.
Current and Future Trends in the Laboratory Diagnosis of Sexually Transmitted Infections
2021
Sexually transmitted infections (STIs) continue to exert a considerable public health and social burden globally, particularly for developing countries. Due to the high prevalence of asymptomatic infections and the limitations of symptom-based (syndromic) diagnosis, confirmation of infection using laboratory tools is essential to choose the most appropriate course of treatment and to screen at-risk groups. Numerous laboratory tests and platforms have been developed for gonorrhea, chlamydia, syphilis, trichomoniasis, genital mycoplasmas, herpesviruses, and human papillomavirus. Point-of-care testing is now a possibility, and microfluidic and high-throughput omics technologies promise to revo…